World's Best Scientists 2026 revealed!
Hildegard Kehrer-Sawatzki

Hildegard Kehrer-Sawatzki

D-Index & Metrics

Genetics

D-Index
46
Citations
11631
World Ranking
4148
National Ranking
278

Hildegard Kehrer-Sawatzki publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Hildegard Kehrer-Sawatzki sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 149 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Hildegard Kehrer-Sawatzki D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Hildegard Kehrer-Sawatzki sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 46 D-Index — 5th percentile

5% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Hildegard Kehrer-Sawatzki is affiliated with the University of Ulm in Germany and specializes primarily in the field of Medicine, with a significant focus on Neurology, Rheumatology, and Molecular Biology. Their research work prominently addresses neurofibromatosis and schwannoma cases, alongside related topics such as soft tissue tumor case studies, sarcoma diagnosis and treatment, chromatin remodeling and cancer, meningioma and schwannoma management, bone tumor diagnosis and treatments, and vascular malformations and hemangiomas.

The scientist has contributed to several frequent publication venues, including Human Genetics, OPAL (Open@LaTrobe) (La Trobe University), Genetics in Medicine, JDDG Journal der Deutschen Dermatologischen Gesellschaft, and the International Journal of Molecular Sciences.

Recent papers authored or co-authored by Hildegard Kehrer-Sawatzki include:

  • Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants, 2021, Human Genetics
  • Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions, 2021, Human Genetics
  • Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation, 2021, Genetics in Medicine
  • Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation, 2022, Genetics in Medicine
  • The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1, 2020, PLoS ONE

Frequent co-authors collaborating with Hildegard Kehrer-Sawatzki include Said Farschtschi, D.N. Cooper, Victor-Felix Mautner, Lennart Well, and Victor F. Mautner.

Their research intersects multidisciplinary aspects within Medicine, focusing extensively on subfields such as Neurology, Rheumatology, and Molecular Biology. The specific topics they engage with involve:

  • Neurofibromatosis and Schwannoma Cases
  • Soft tissue tumor case studies
  • Sarcoma Diagnosis and Treatment
  • Chromatin Remodeling and Cancer
  • Meningioma and schwannoma management
  • Bone Tumor Diagnosis and Treatments
  • Vascular Malformations and Hemangiomas

Best Publications

  • Encyclopedia of life sciences

    Yixian Zheng;Cheryl Tickle;Roland Jansson;Hildegard Kehrer-Sawatzki

  • Evolutionary and biomedical insights from the rhesus macaque genome

    Richard A. Gibbs;Jeffrey Rogers

  • Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease

    David Neil Cooper;Michael Krawczak;Constantin Polychronakos;Chris Tyler-Smith

  • Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.

    E Legius;L Messiaen;P Wolkenstein;P Pancza

  • PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies

    Thomas De Raedt;Eline Beert;Eric Pasmant;Armelle Luscan

  • A high density of X-linked genes for general cognitive ability: a run-away process shaping human evolution?

    Ulrich Zechner;Monika Wilda;Hildegard Kehrer-Sawatzki;Walther Vogel

  • Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene.

    Lan Kluwe;Reiner Siebert;Stefan Gesk;Reinhard E. Friedrich

  • Genes, Mutations, and Human Inherited Disease at the Dawn of the Age of Personalized Genomics

    David Neil Cooper;Jian-Min Chen;Edward Vincent Ball;Katy Howells

  • Emerging genotype–phenotype relationships in patients with large NF1 deletions

    Hildegard Kehrer-Sawatzki;Victor-Felix Mautner;David N. Cooper

  • Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions

    V. F. Mautner;L. Kluwe;R. E. Friedrich;A. C. Roehl

  • Recombination hotspot in NF1 microdeletion patients

    Catalina López-Correa;Michael Dorschner;Hilde Brems;Conxi Lázaro

  • High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene

    H. Kehrer-Sawatzki;L. Kluwe;C. Sandig;M. Kohn

  • Genomic rearrangements in inherited disease and cancer.

    Jian-Min Chen;David Neil Cooper;Claude Férec;Hildegard Kehrer-Sawatzki

  • Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions.

    Dieter E. Jenne;Sigrid Tinschert;Heike Reimann;Wolfgang Lasinger

  • Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients.

    K. Wimmer;S. Yao;K. Claes;H. Kehrer-Sawatzki

  • The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis

    Hildegard Kehrer-Sawatzki;Said Farschtschi;Victor-Felix Mautner;David Neil Cooper

  • On the sequence-directed nature of human gene mutation: the role of genomic architecture and the local DNA sequence environment in mediating gene mutations underlying human inherited disease.

    David Neil Cooper;Albino Bacolla;Claude Férec;Karen M. Vasquez

  • Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1)

    Ludwine Messiaen;Julia Vogt;Kathrin Bengesser;Chuanhua Fu

  • Reconstruction of a 450-My-old ancestral vertebrate protokaryotype

    Matthias Kohn;Josef Högel;Walther Vogel;Peter Minich

  • The second case of a t(17;22) in a family with neurofibromatosis type 1: sequence analysis of the breakpoint regions

    Hildegard Kehrer-Sawatzki;Jürgen Häussler;Winfried Krone;Harald Bode

Frequent Co-Authors

David Neil Cooper
David Neil Cooper Cardiff University
Horst Hameister
Horst Hameister University of Ulm
Ludwine Messiaen
Ludwine Messiaen University of Alabama at Birmingham
Nadia Chuzhanova
Nadia Chuzhanova Nottingham Trent University
Eric Legius
Eric Legius KU Leuven
Conxi Lázaro
Conxi Lázaro Institut d'Investigació Biomédica de Bellvitge
Meena Upadhyaya
Meena Upadhyaya Cardiff University
Dieter E. Jenne
Dieter E. Jenne Max Planck Society
Walther Vogel
Walther Vogel University of Ulm
Kathleen Claes
Kathleen Claes Ghent University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in genetics, a variety of financial aid for medical billing and coding programs are available online, offering an alternative entry point into healthcare professions. These programs can provide fundamental healthcare knowledge while helping students manage educational costs.

Many universities now offer accelerated colleges and degree pathways, allowing motivated students to fast-track their education and enter the workforce sooner—ideal for those eager to begin careers in genetics or biotech fields.

Flexibility is another key benefit of modern learning. There are numerous online self paced colleges where you can study at your own convenience, making it easier to balance coursework with work or family commitments.

Additionally, some institutions offer the advantage of being colleges with free application fees, reducing barriers for prospective students to apply to multiple programs and find the best fit for their career aspirations in genetics and related areas.

Best Scientists Citing Hildegard Kehrer-Sawatzki

Trending Scientists

Recently Published Articles